215 related articles for article (PubMed ID: 33072190)
1. Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia.
Tao Z; Zhang L; Friedemann T; Yang G; Li J; Wen Y; Wang J; Shen A
J Funct Foods; 2020 Dec; 75():104243. PubMed ID: 33072190
[TBL] [Abstract][Full Text] [Related]
2. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study.
Xia L; Shi Y; Su J; Friedemann T; Tao Z; Lu Y; Ling Y; Lv Y; Zhao R; Geng Z; Cui X; Lu H; Schröder S
Phytomedicine; 2021 May; 85():153390. PubMed ID: 33158717
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic effect of Shufeng Jiedu capsule and its major herbs on coronavirus disease 2019 (COVID-19): A review.
Xu Y; Yang L; Wang L; Chen F
Drug Discov Ther; 2022 Jan; 15(6):289-299. PubMed ID: 34980761
[TBL] [Abstract][Full Text] [Related]
4. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology.
Chen X; Yin YH; Zhang MY; Liu JY; Li R; Qu YQ
Int J Med Sci; 2020; 17(16):2511-2530. PubMed ID: 33029094
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the active components and mechanism of Shufeng Jiedu capsule against COVID-19 based on network pharmacology and molecular docking.
Simayi J; Nuermaimaiti M; Wumaier A; Khan N; Yusufu M; Nuer M; Maihemuti N; Bayinsang ; Adurusul K; Zhou W
Medicine (Baltimore); 2022 Jan; 101(1):e28286. PubMed ID: 35029877
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation.
Zhuang Z; Zhong X; Zhang H; Chen H; Huang B; Lin D; Wen J
Comb Chem High Throughput Screen; 2021; 24(9):1377-1394. PubMed ID: 33135607
[TBL] [Abstract][Full Text] [Related]
7. Systems pharmacology approach to explore the mechanisms of shufeng Jiedu Capsule on treating H1N1 infection.
Mei Z; Zhang J; Chen X; He Y; Feng J; Du Y; Shi J; Jie Z
Drug Dev Ind Pharm; 2023 Jun; 49(6):405-415. PubMed ID: 37279006
[TBL] [Abstract][Full Text] [Related]
8. Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule.
Zhang J; Liu L; Zhang G; Li M; Ma B; Yang W
Biosci Trends; 2022 Jul; 16(3):238-241. PubMed ID: 35732417
[TBL] [Abstract][Full Text] [Related]
9. Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma.
Xia J; Rong L; Sawakami T; Inagaki Y; Song P; Hasegawa K; Sakamoto Y; Tang W
Biomed Pharmacother; 2018 Mar; 99():921-930. PubMed ID: 29710492
[TBL] [Abstract][Full Text] [Related]
10. Study on basic and clinical application of Shufeng Jiedu Capsule in treating respiratory tract infection.
Han Y; Xu J; Zhu Q; Yang L; Wang Y; Luo H; Zhang T
Chin Med; 2023 Apr; 18(1):45. PubMed ID: 37098552
[TBL] [Abstract][Full Text] [Related]
11. Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.
Ji S; Bai Q; Wu X; Zhang DW; Wang S; Shen JL; Fei GH
Biomed Pharmacother; 2020 Jan; 121():109652. PubMed ID: 31734578
[TBL] [Abstract][Full Text] [Related]
12. Identification of absorbed components and their metabolites in rat plasma after oral administration of Shufeng Jiedu capsule using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
Liu X; Zhang H; Xu J; Gong S; Han Y; Zhang T; Liu C
Rapid Commun Mass Spectrom; 2019 Oct; 33(19):1494-1501. PubMed ID: 31148270
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Mechanistic Studies of ShuFengJieDu Capsule in an Acute Lung Injury Animal Model Using Quantitative Proteomics Technology.
Tao Z; Meng X; Han YQ; Xue MM; Wu S; Wu P; Yuan Y; Zhu Q; Zhang TJ; Wong CCL
J Proteome Res; 2017 Nov; 16(11):4009-4019. PubMed ID: 28880561
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences.
Banerjee S; Baidya SK; Adhikari N; Ghosh B; Jha T
J Mol Struct; 2023 Mar; 1275():134642. PubMed ID: 36467615
[TBL] [Abstract][Full Text] [Related]
15. A comparison of COVID-19, SARS and MERS.
Hu T; Liu Y; Zhao M; Zhuang Q; Xu L; He Q
PeerJ; 2020; 8():e9725. PubMed ID: 32879801
[TBL] [Abstract][Full Text] [Related]
16. A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
de Wilde AH; Wannee KF; Scholte FE; Goeman JJ; Ten Dijke P; Snijder EJ; Kikkert M; van Hemert MJ
J Virol; 2015 Aug; 89(16):8318-33. PubMed ID: 26041291
[TBL] [Abstract][Full Text] [Related]
17. Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19.
Patil R; Chikhale R; Khanal P; Gurav N; Ayyanar M; Sinha S; Prasad S; Dey YN; Wanjari M; Gurav SS
Inform Med Unlocked; 2021; 22():100504. PubMed ID: 33363251
[TBL] [Abstract][Full Text] [Related]
18. Traditional Chinese Medicine as the preventive and therapeutic remedy for COVID-19.
Gasmi A; Tippairote T; Mujawdiya PK; Menzel A; Lysiuk R; Shanaida M; Lenchyk L; Peana M; Bjørklund G
Curr Med Chem; 2023 Mar; ():. PubMed ID: 36999715
[TBL] [Abstract][Full Text] [Related]
19. Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101).
Su YC; Huang GJ; Lin JG
Front Pharmacol; 2022; 13():928106. PubMed ID: 36278162
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone.
Lawal B; Kuo YC; Rachmawati Sumitra M; Wu ATH; Huang HS
Comput Biol Med; 2022 Sep; 148():105814. PubMed ID: 35841781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
